Craft

Acarix

Stock Price

KR0.3

2024-10-29

Market Capitalization

KR339.3 M

2024-10-29

Revenue

KR7.4 M

FY, 2025

Acarix Summary

Company Summary

Overview
Acarix is a company that develops medical devices for the treatment of coronary artery disease (CAD). It offers the Acarix CADScorSystem, a device that records and processes heart sounds. The system detects turbulent arterial flow and myocardial movement and provides a CAD-score on the screen.
Type
Public
Status
Active
Founded
2009
HQ
Malmö, SE | view all locations
Website
https://www.acarix.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Christian Lindholm

    Christian Lindholm, Chief Financial Officer

    • Per Persson

      Per Persson, Chief Executive Officer

      LocationsView all

      2 locations detected

      • Malmö, Skåne län HQ

        Sweden

        Jungmansgatan 12

      • Hellerup

        Denmark

        Ryvangs Allé 81

      Acarix Financials

      Summary Financials

      Revenue (FY, 2025)
      kr7.4M
      Gross profit (FY, 2025)
      kr6.2M
      Net income (FY, 2025)
      (kr48.1M)
      Cash (FY, 2025)
      kr18.3M
      EBIT (FY, 2025)
      (kr48.0M)

      Footer menu